UNITED
NATIONS

E


Economic and Social Council

Distr.
GENERAL

E/RES/1968/1293(XLIV)
1520th Plenary Meeting
23 May 1968


1968/1293(XLIV).National legislative measures for the control of psychotropic substances not under international control*/

 

The Economic and Social Council,

Concerned at the contuing problem posed by the abuse of psychotropic substances not under international control (amphetamines, barbiturates, hallucinogens, tranquilizers),

Recalling the recommendations adopted by the Commission on Narcotic Drugs at its twenty-first session on control measures for these substances,27/

Recalling also resolution WHA 20.43 of the Twentieth World Health Assembly on control measures for these dependence-producing drugs,28/

Learning with satisfaction that the Commission on Narcotic Drugs, with the co-operation of the World Health Organization and the International Narcotics Control Board, is advancing its work to determine the best form of treaty action by which to apply to these substances national controls by international agreement, together with a measure of international control,

Noting that, while this work progresses, it will still require time to implement the international action that is contemplated,

Recommends Governments to adopt legislation, if they have not already done so, to give effect to the following measures of national control over the above-mentioned psychotropic substances:

(a) Availability on medical prescription only;

(b) Supervision of all transactions from production to retail distribution;

(c) Licensing of all producers;

(d) Limitation of trade to authorized persons;

(e) Prohibition of non-authorized possession for distribution.

1520th plenary meeting,
23 May 1968
.

27/ See Official Records of the Economic and Social Council, Forty-second Session, Supplement No. 2 (E/4294), para. 296 and annex II, para. 20.

28/ See World Health Organization, Handbook of resolutions and decisions of the World Health Assembly and the Executive Board, 1948-1967 (Geneva, 1967), p. 109.

*/ Adopted as recommended by the Commission on Narcotic Drugs in its resolution 5(XXII) (E/4455-E/CN.7/512, para. 325 and chap. X draft resolution E), with minor amendments.